Objective-The serum level of tumor necrosis factor-␣ (TNF-␣) is in the picomolar range under inflammatory conditions.
T umor necrosis factor (TNF)-␣ is one of the representative cytokines modulating immune and inflammatory responses at the site of local inflammation. TNF-␣, mainly produced by macrophages, 1 regulates genes responsible for the recruitment of monocytes, such as VCAM-1 and E-selectin 2 and monocyte chemoattractant protein-1 (MCP-1), by endothelial cells. 3 The crucial role of TNF-␣ in monocyte recruitment was confirmed previously in vivo, whereby genetic disruption of a specific TNF receptor I (TNFRI or p55) resulted in less severe infiltration of inflammatory leukocytes to the wound area. 4 TNF-␣ additionally triggers exacerbated inflammatory responses in recruited monocytes/macrophages, such as production of inflammatory cytokines, oxygen radicals, 5 and matrix metalloproteinase-9. 6 We previously showed that activities of monocytes determining the efficiency of recruitment are affected by a number of factors in blood (ie, lipoproteins, C-reactive protein, and pharmacological agents, such as a HMG-CoA reductase inhibitor and a PPAR␥ agonist [see review 7 ] ). The serum level of TNF-␣, which is nearly undetectable at steady-state, is profoundly elevated (to the picomolar range) under inflammatory conditions. 8 Interestingly, TNF-␣ shows high-affinity binding to specific receptors, such as TNFRI (p55 or CD120a) and TNFRII (p75 or CD120b) 9 in myeloid cell lines, including monocytes, with dissociation constants (K d ) of 6.5 to 7.1ϫ10 Ϫ11 mol/L. 10, 11 Therefore, we hypothesized that the functional activities of circulating monocytes are affected by picomolar levels of TNF-␣ in the blood circulation.
In the present study, we elucidate the mechanism by which monocyte recruitment to inflammatory foci is effectively potentiated by TNF-␣. We obtain novel evidence that TNF-␣ in the picomolar range stimulates the rapid translocation of RhoA small GTPase to the plasma membrane, which effectively preconditions monocytes to enhance their activities, such as chemotaxis, firm adhesion, and transmigration.
RPMI 1640 medium (BioWhittaker) containing 10% low endotoxin fetal calf serum (Hyclone). 12 CD14 (ϩ) human monocytes were isolated from peripheral blood mononuclear cells by negative selection using MiniMACS separation columns (Miltenyi Biotec GmbH). 12 Monocyte purity was Ͼ80%, as estimated by flow cytometry using anti-CD14 IgG. HEK293 cells (Invitrogen) were maintained in F-12K medium (Kaighn modification of Ham's F-12 medium) and DMEM with high glucose, 10% FBS, and antibiotics. We confirmed that all reagents used to treat cells were not cytotoxic at working concentrations. Expression vector encoding wild type (WT) and T567D, a constitutively active form of ezrin, were kindly provided by Dr M. Arpin [Institute Curie, UMR 144 CNRS (Centre National de la Recherche Scientifique), Paris, France]. 13 All animals were raised under specific pathogen-free conditions, and the protocol was reviewed and approved by the Animal Subjects Committee of Asan Medical Center (Seoul, South Korea). 
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Vertical Chamber Migration Assay
A vertical glass chamber containing a 2-mm-thick liquid phase collagen gel (Chemicon) was prepared. MCP-1 (final concentration of 1 nmol/L) was mixed with the lower one-fifth of the gel, and the bottom of the chamber immersed in prewarmed phenol red-free RPMI 1640 medium containing 0.1% BSA. Freshly isolated human monocytes were labeled with DiI (red) or DiO (green) fluorescent dye (Molecular Probes). DiI-labeled monocytes were pretreated with TNF-␣ (10 pmol/L/30 minutes). DiI-and DiO-labeled cells (10 5 ) were mixed and seeded on the top surface of the prepared collagen gel. After incubation (37°C/6 hours in 5% CO 2 ), images of human monocytes in the upper, middle, and lower parts of the chamber were captured by confocal microscopy using a TCS-SP2 system (Leica Microsystems). Spontaneous migration of human monocytes was estimated by performing a parallel experiment in the absence of MCP-1.
Estimation of Monocyte Recruitment to the Peritoneal Cavity
JE/MCP-1 (200 ng; R&D Systems) was injected into the peritoneal cavities of 4-week-old male C57/BL6 mice (nϭ8). In an experimental subset, 1 g TNF-␣ was intraperitoneally coinjected to elevate the serum TNF-␣ level (nϭ8). Mice were euthanized after 16 hours, and 10 mL PBS-containing 10 4 PE-conjugated microbeads (Becton Dickinson) were injected into individual peritoneal cavities. Cells and beads in the suspension were withdrawn after 2 to 3 minutes and pelleted by centrifugation (500g, 5 minutes, 4°C). To label monocytes/macrophages, each cell preparation was incubated with 0.5 g PE-conjugated anti-CD80 antibody in the presence of 5 g unlabeled nonspecific mouse IgG. The number of CD80 (ϩ) cells per 10 3 PE-conjugated microbeads was counted using FACScan, and the total number of CD80 (ϩ) cells in each peritoneal cavity calculated. expressed as meansϮSD. The differences between 2 groups were determined from the results of an unpaired Student t test, and those between multiple groups were evaluated with 2-way ANOVA where appropriate. Differences were considered statistically significant at PϽ0.05.
Statistical Analysis
Results
TNF-␣ Stimulates RhoA Translocation to the Plasma Membrane of THP-1 Monocytes Through TNFRI
Rho family small GTPases including RhoA are key mediators of cytoskeletal remodeling, cell-cell adhesion, and chemotaxis. 14 Immunoblotting assay showed that treatment of THP-1 human monocytes with Ն1 pmol/L TNF-␣ resulted in rapid translocation of RhoA and Rho-GDI from cytosol to the plasma membrane in 30 minutes (PϽ0.05, ANOVA). Conversely, the RhoA and Rho-GDI levels in the cytosol showed reciprocal patterns (PϽ0.05, ANOVA) ( Figure 1A ). The trafficking of RhoA in TNF-␣-treated monocytes was inhibited by neutralizing antibody against TNFRI, not TNFRII ( Figure 1B ). The novel ability of TNF-␣ to upregulate membrane-associated RhoA protein levels was further confirmed by calculating the B max value of specific [ 35 S]GTP␥S binding, which reflects the mass of membrane-associated GTP-binding sites, including small GTPases. As expected, TNF-␣ (1 to 10 pmol/L for 30 minutes) enhanced specific [
35 S]GTP␥S binding by up to 60% (PϽ0.05, ANOVA) in a dose-dependent manner, which was suppressed by functional blocking of TNFRI (please see supplemental Figure I ). Immunoblotting assay further showed that the TNF-␣-induced (10 pmol/L/30 minutes) mobilization of RhoA to the plasma membrane was dependent on actin polymerization and number of signaling pathways involving NF-B, PKC, and PI3K ( Figure 1C ).
Ezrin/Radixin/Moesin Complex Is Phosphorylated by TNF-␣/TNFRI and Triggers RhoA Mobilization to the Plasma Membrane
The ezrin/radixin/moesin (ERM) complex is activated by phosphorylation, in turn promoting actin polymerization as a prerequisite for mobilization of cytosolic RhoA and the Rho-GDI complex. 15, 16 Immunoblotting assay proved that on the addition of 10 pmol/L TNF-␣, threonine residues of ERM were rapidly phosphorylated within 5 minutes (Figure 2A ). Ezrin/radixin/moesin complex, phosphorylated by TNF-␣/TNFRI and subsequent activation of atypical PKC and PI3K, is responsible for RhoA mobilization. A, THP-1 monocytes were treated with 10 pmol/L TNF-␣ for up to 60 minutes, and total (Total ERM) or threoninephosphorylated ezrin/radixin/moesin (pERM) protein in cell lysate detected with the immunoblotting assay. Results are presented as meanϮSD of experiments performed in triplicate. *PϽ0.05, **PϽ0.01 vs untreated control (0 minutes) with the unpaired Student t test. B, Either scramble RNA, specific siRNA against ezrin, or, wild-type (WT), T567D mutant ezrin, or mock vector was transfected to THP-1 monocytes overnight. The transfected THP-1 monocytes were treated with TNF-␣ as described in A and RhoA or G␤ subunit the plasma membrane were detected using immunoblotting. C, THP-1 monocytes were pretreated for 30 minutes with 10 g/mL anti-TNFRI or RII antibodies, 100 mol/L PDTC, 10 mol/L GF109203X, and 100 nmol/L LY294002 followed by TNF-␣ (10 pmol/L/10 minutes) and total ERM and pERM in cell lysates detected with the immunoblotting assay. Results are presented as meanϮSD of experiments performed in triplicate. PϽ0.05, PϽ0.01, and NS (statistically nonsignificant) with the unpaired Student t test. D, Either scramble RNA or specific siRNA against isoforms of PKCs (␣, ␤, ␦, or ) was transfected to THP-1 monocytes and total ERM and pERM in cell lysates detected with the immunoblotting assay as described in C. E, Either scramble RNA or specific siRNA against PI3K was transfected to THP-1 monocytes and total ERM and pERM in cell lysates detected with the immunoblotting assay as described in C. F, Either scramble RNA or specific siRNA against PI3K was transfected to THP-1 monocytes. THP-1 monocytes were pretreated for 30 minutes with 100 nmol/L LY294002, 10 mol/L Gö 6983, and 10 mol/L GF109203X, and total amount (total PKC) or phosphorylated form of PKC (pPKC) was detected in TNF-␣-treated THP-1 monocytes using immunoblotting.
We modulated ezrin expression through transfection of specific siRNA, or expression vectors encoding wild-type or constitutionally active form of ezrin (ie, T567D mutant form 13 ; please see supplemental Figure II ). Ezrin siRNA downregulated ezrin and blocked the effect of TNF-␣ on RhoA mobilization. Conversely, the induction of T567D ezrin sufficiently induced RhoA mobilization ( Figure 2B ), suggesting ERM complex plays a key role in the translocation of RhoA to the plasma membrane in TNF-␣-treated monocytes.
Immunoblotting assay further showed that TNF-␣/TNFRIinduced ERM phosphorylation was significantly blocked by a PKC inhibitor and a PI3K inhibitor ( Figure 2C ). Monocytes/ macrophages express 8 PKC isoforms (␣, ␤I, ␤II, ␦, , , , and ). 17 Among PKC inhibitors, both GF109263X (inhibiting ␣, ␤I, ␦, and ) and Gö6983 (inhibiting ␣, ␤, ␦, and ) blocked the ERM phosphorylation, whereas Gö6976 (inhibiting ␣ and ␤) had no effects, suggesting the involvement of ␦ (a novel PKC; nPKC) or subtypes (an atypical PKC; aPKC; please see supplemental Figure III ). We transfected specific siRNAs against specific isoforms of PKC (␣, ␤, ␦, and ) or against PI3K, respectively, and measured the change of TNF-␣-induced ERM phosphorylation. Specific siRNAs against PKC and PI3K downregulated mRNA expression levels (please see supplemental Figure VI ) and significantly blocked the TNF-␣/TNFRI-induced ERM phosphorylation ( Figure 2D and 2E) . Immunoblotting assay further showed the direct activation of PKC by picomolar TNF-␣, which was blocked by PI3K siRNA, suggesting PI3K is upstream of PKC ( Figure 2F ). 
Rearrangement of Actin Is Mediated by ERM-Stimulated NF-B Activity
Flow cytometry analyses using rhodamine-conjugated phalloidin showed clear cytoskeletal rearrangement of TNF-␣-treated THP-1 monocytes (10 pmol/L/30 minutes). As expected, TNF-␣-stimulated actin polymerization was found to be through PKC, PI3K, and the activation of ezrin ( Figure  3A) . Interestingly, NF-B also mediated TNF-␣-stimulated actin polymerization ( Figure 3A) , too. Promoter assay showed that NF-B activation was directly induced by expression of T567D ezrin without TNF-␣ treatment ( Figure  3B ). Flow cytometry analyses showed that the specific inhibition of NF-B blocked actin polymerization in both TNF-␣-treated (10 pmol/L/30 minutes) and T567D ezrintransfected monocytes, suggesting NF-B activity is required for ERM-induced actin polymerization ( Figure 3C ).
TNF-␣ Potentiates the Magnitude of MCP-1/CCR2-Mediated RhoA Activation
To establish whether the substantial increase in membraneassociated RhoA by picomolar TNF-␣ enhances the extent of RhoA activation, we activated CC chemokine receptor 2 (CCR2), a G protein-coupled receptor (GPCR) in monocytes, by adding its specific ligand, monocyte chemoattractant protein (MCP)-1, 18 and quantified GTP-bound RhoA using a pull-down assay. The rapid generation of GTP-bound RhoA detected in response to 1 nmol/L MCP-1 within 5 minutes was potentiated and prolonged by 10 pmol/L TNF-␣ ( Figure 4A ). We further found that 10 pmol/L TNF-␣ stimulated RhoA and Rac activities, but this direct activation was not evident until 15 minutes after the stimulation ( Figure  4A and 4B) . The latent activation of RhoA and Rac by TNF-␣ was significantly blocked by a specific siRNA against PI3K ( Figure 4B ).
THP-1 Monocytes Preconditioned With Picomolar TNF-␣ Display Enhanced MCP-1/CCR2 Activities
Both human circulating and THP-1 cultured monocytes express comparable amounts of CCR2 (Ϸ5000/cell) and MCP-1-stimulated CCR2 activation exhibits potent chemotaxis and cellular adhesion. 7 A chemotaxis assay clearly disclosed that TNF-␣ (10 pmol/L/30 minutes) preconditioned THP-1 monocytes to develop 7-fold more efficient chemotactic movement in response to 1 nmol/L MCP-1, which was abolished by functional ablation of ezrin using specific siRNA ( Figure 5A ). Unlike MCP-1, TNF-␣ did not directly trigger chemotaxis, but enhanced the random movement of monocytes ("chemokinesis") to a mild degree (data not shown). Freshly isolated human monocytes displayed clear directional movement toward 1 nmol/L MCP-1 in a vertical chamber ex vivo, which was significantly enhanced on pretreatment with TNF-␣ (10 pmol/L/30 minutes). Such MCP-1-induced transmigratory activities of human monocytes were completely jeopardized by ezrin siRNA ( Figure  5B ), too.
MCP-1/CCR2 immediately activates ␣ integrins on the monocyte surface, promoting integrin-mediated firm adhesion and subsequent transmigration. 19 Adhesion assay using plates coated with human recombinant ICAM-1 or VCAM-1, specific ligands for ␣ integrins, showed that TNF-␣ (10 pmol/L/30 minutes) increased MCP-1-induced firm adhesion, implying TNF-␣ amplifies MCP-1/CCR2-triggered ␣ integrin activation. As observed in the chemotaxis assay, the functional ablation of ezrin using specific siRNA abolished the increasing effect of TNF-␣ on both ICAM-1-and VCAM-1-mediated adhesion ( Figure 5C and 5D ).
Picomolar TNF-␣ in the Circulation Facilitates Monocyte/Macrophage Accumulation in JE/MCP-1-Injected Mouse Peritoneal Cavity
ELISA analyses confirmed that intraperitoneal injection of 1 g TNF-␣ elevated the serum level up to 5 pmol/L between 8 to 16 hours after injection ( Figure 6A) , therefore, we quantified the intraperitoneal CD80 (ϩ) monocytes/macrophages 16 hours after TNF-␣ injection. We also confirmed that the injection of 200 ng JE/MCP-1 intraperitoneally did not affect the serum TNF-␣ level within 24 hours (data not shown) and clearly induced CD80 (ϩ) monocyte recruitment into the peritoneal cavity ( Figure 6B ), as determined by flow cytometry. The injection of TNF-␣ considerably enhanced JE/MCP-1-mediated recruitment of CD80 (ϩ) monocytes. The number of intraperitoneal CD80 (ϩ) monocytes in mice injected with both JE/MCP-1 and TNF-␣ was Ͼ4-fold higher than that in untreated littermates and Ͼ2-fold higher relative to JE/MCP-1-or TNF-␣-treated mice ( Figure 6B ).
Discussion
Circulating monocytes can be exposed to picomolar levels of TNF-␣ in the blood stream under inflammatory conditions. In the present study, we present novel evidence that Either scramble RNA or specific siRNA against PI3K was transfected to THP-1 monocytes overnight and THP-1 monocytes were pretreated with 10 pmol/L TNF-␣ for 30 minutes and stimulated with 1 nmol/L MCP-1 for up to 15 minutes. The amounts of GTP-bound or total RhoA and Rac were estimated with a pull-down assay. Positive and negative controls were examined in parallel in the presence of excess GDP and unlabeled ␥SGTP, respectively. picomolar TNF-␣ rapidly mobilizes a substantial amount of RhoGDI-bound RhoA from the cytosol to plasma membrane and this process requires the activation of TNFRI, a member of the TNFR superfamily, and subsequent phosphorylation of threonine residues in the ezrin/ radixin/moesin (ERM) protein complex and actin rearrangement. Several PKCs can phosphorylate threonine residue of ERM. 20 We first identified that PKC, an atypical PKC (aPKC) is responsible for ERM phosphorylation in human monocytes. A previous study described that the PKC activation triggered by TNF-␣-bound TNFRI is through physical interaction with TRAF6, 21 which in turn mediates the TNFRI-derived activation of PI3K. 22 Our study also provides evidence that PKC activation in human monocytes is largely through PI3K. Our data additionally support the involvement of NF-B in RhoA traffic. Previous studies suggest the NF-B activation by PKC, in which TNFRI-derived PKC directly interacts with the IKK complex and phosphorylation of p65 in a DNA-binding Rel homology domain 21 ; however, our study clearly showed that PKC-mediated NF-B activation did not regulate ERM phosphorylation. We found that NF-B is a downstream signal of ERM activity and mediates subsequent actin polymerization as a prerequisite for RhoA mobilization.
The picomolar TNF-␣ concentration required for ERM phosphorylation in monocytes was at least 100 times lower than that described earlier with pulmonary microvascular endothelial cells, 23 suggesting monocytes in the blood circulation may contain more abundant membrane-bound RhoA under active inflammatory conditions. To analyze the functional relevance of RhoA mobilization, we se- lected the MCP-1/CCR2 system, which involves RhoAmediated signals and regulates critical functions of monocytes, such as integrin-mediated firm adhesion 24 and chemotactic movement. 25 TNF-␣ had been described as a negative regulator of monocyte recruitment in view of previous data showing the complete and rapid internalization of monocyte CCR2 on stimulation with nanomolar TNF-␣. 26 In the present study, we did not observe any significant changes in CCR2 surface expression at 10 pmol/L (or lower) TNF-␣. A series of in vitro, ex vivo, and in vivo functional analyses clearly show opposite effects of picomolar TNF-␣ on the efficiency of the monocyte MCP-1/CCR2 system, specifically, potentiation of RhoA activation and the related cell signaling, and the transmigration of monocytes.
The enhanced migratory activity of TNF-␣-treated monocytes toward MCP-1 in vitro and in vivo may be predominantly attributed to the increased availability of RhoA for CCR2 activation. A previous study supports our findings that monocytes with constitutively active RhoA display improved firm adhesion and transmigration properties. 27 Our pull-down assay revealed similar conditions, in which secondary stimulation of TNF-␣-treated monocytes with MCP-1 triggers amplified and prolonged GTPbound RhoA production. Second, we found that monocytes treated with picomolar TNF-␣ directly generated both GTP-bound Rac as well as RhoA. The activation of RhoA and Rac by nanomolar levels of TNF-␣ had been previously described in vascular endothelial 28 and fibroblast 29 cell lines. The detailed mechanism by which TNF-␣ induces RhoA and Rac activation is not clear. Previous studies describe that the phosphorylation of RhoGDI may release the bound Rho family small G proteins such as RhoA and Rac1. 30 Kuribayashi et al examined human circulating monocytes and reported that PKC induces threonine phosphorylation of RhoGDI, which liberated RhoA and Rac1 leading to their activation. 31 Therefore, it is highly possible that TNF␣/TNFRI-induced PKC activation, as shown in the present study, may result in threonine phosphorylation of RhoGDI and induce the release of the bound RhoA and Rac1, which may promote the conversion of free RhoA and Rac1 to GTP-bound active forms as proved by our pull-down assay.
Together with functional RhoA, which contributes to tail retraction, Rac activity inducing the protrusion of the leading edge is required for effective transmigration. 14 Functionally active Rac also dephosphorylates ERM and directly inhibits its antimigratory function (ie, retardation of tail retraction 14 ) . Therefore, our observations show simultaneous activation of RhoA and Rac may orchestrate TNF-␣-treated monocytes for efficient transmigratory movement. The present study highly suggests that TNF-␣-induced activation of RhoA and Rac in monocytes is mediated by PI3K activation. As discussed earlier, PI3K is one of downstream signals of TNF-␣/TNFRI to induce ERM phosphorylation. Moreover, a previous study described that phosphorylated ERM complex directly activates PI3K by binding to its regulatory subunit (p85). 32 Therefore, functional activities of PI3K and ERM in TNF-␣-treated monocytes may become potent through positive feedback loop, which may eventually upregulate TNF-␣-induced activation of RhoA and Rac as well as RhoA mobilization.
In conclusion, our data collectively provide evidence that monocyte functions pertinent to recruitment are primed by humoral factors under inflammatory conditions. The effect of TNF-␣ on transmigration was found to be largely dependent on the concentration. In contrast to higher concentrations, picomolar TNF-␣ enhances monocyte activities, such as chemotaxis, firm adhesion, and transmigration, primarily through translocation of RhoA small GTPase to the plasma membrane. These priming effects of picomolar TNF-␣ on circulating monocytes may contribute to more vigorous recruitment to inflammatory foci. 1 g) , or vehicle (PBS ϩ0.1% BSA) was injected into the peritoneal cavities of C57/BL6 mice (nϭ3). Time-dependent changes in the serum TNF-␣ level in mice were measured using an ELISA kit. Probability values were determined with the unpaired Student t test. B, JE/MCP-1 (200 ng) or TNF-␣ (1 g) were injected into the peritoneal cavities of C57/BL6 mice (nϭ8 each). Sixteen hours later, the CD80 (ϩ) cell number in the peritoneal cavity was evaluated, as described in Methods. Probability values were determined with the unpaired Student t test.
